Anthropic pays $400M for biotech; Praxis epilepsy drug hits in Phase 1/2 trial
Plus: Debt financing deals for Apnimed and Opus Genetics Anthropic buys a stealth biotech: The San Francisco artificial intelligence giant is buying Coefficient Bio, building out its plans to bring AI into life sciences. Anthropic ...
Original Source
Read the full article at Endpoints →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.